Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :


By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :


Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

FSD Pharma Now Licensed to Sell to other LPs

Stockhouse Editorial
0 Comments| November 13, 2018

FSD Pharma Inc. (CSE: HUGEOTCQB: FSDDFForum) stated on Tuesday that it has received a license to sell to other licensed producers through its wholly-owned subsidiary, FV Pharma Inc. under the Access to Cannabis for Medical Purposes Regulations. The Company is also expanding its growth production footprint.

For more on this, click here.

FSD was in the news recently when it announced that that its partner, SciCann Therapeutics Inc., received a positive International Search Authority report from the Patent Cooperation Treaty for its SCN-001 cannabidiol combination therapy patent, the basis of FSD’s “Steady Stomach” product. 

FULL DISCLOSURE: FSD Pharma Inc. is a paid client of Stockhouse Publishing.

Interested in these industries and sectors?

Receive investor kits and email updates from Stockhouse and directly from these companies.

Metals & Mining

Interested in these industries and sectors?

You are already a member! Please enter your password to sign in.


No comments yet. Be first to comment!

Leave a Comment

You must be logged in to access this feature.


Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.